Search results for: 'edg ai solution'

This Frost & Sullivan market insight presents an overview of the artificial intelligence (AI) initiatives powering the next-generation business support system (BSS) initiatives in the global mobile communications market. It describes the various opportunities that generative AI (Gen AI) supports with the enhancement of existing BSS functions and pr...

The convergence of networking and security has become a business necessity. Organizations rapidly adopt cloud-first strategies, hybrid work models, and multicloud environments, making traditional perimeter-based security architectures obsolete. Secure access service edge (SASE) integrates networking and security into a unified, cloud-delivered fram...

As global clinical pipelines witness a surge in complex novel therapies, there is a general inclination toward improving trial design through adaptive trial designs with technology-enabled solutions for planning and execution. Artificial intelligence (AI) is gaining large-scale recognition in terms of supporting decentralized trial designs and allo...

This Frost Radar™ analyzes the clinical ambient AI solutions that enable clinicians to improve their efficiency at the point of care. AI scribe capability has become the baseline market requirement, eliminating it as a differentiator and pushing vendors to compete on higher-order clinical and financial workflow integration. These capabilities inclu...

09 Sep 2024  |  Global  |  Technology Research

AI-based Drug Repurposing Market, Growth Opportunities, Global, 2024-2029

AI-based Drug Repurposing is emerging as a new and faster approach to bringing drugs to patients.

Infographics

×

This study analyzes the emergence of AI-based drug repurposing and examines the factors driving and hindering adoption. The limitation of traditional drug discovery has led to the growing interest in AI -based drug repurposing, which offers numerous advantages in terms of time, speed, and cost. AI-based drug repurposing has been explored across dif...

Clinical genomics regained significance during the pandemic with the development of the mRNA COVID-19 vaccine, and several non-invasive at-home test kits; an unprecedented feat in recent times. Genomics will take center stage, as large genome sequencing and research will continuously create data for new therapeutics. Artificial Intelligence (AI) an...

AI-enhanced formulation transforms how advanced materials are designed, optimized, and commercialized, shifting from empirical experimentation to predictive, data-driven discovery. By combining AI, ML, and materials informatics, formulators can simulate and optimize complex multi-component systems, accelerating performance tuning, improving sustain...

This Frost & Sullivan analysis examines the clinical next-generation sequencing (NGS) industry, covering the different type of products, workflows, and applications for clinical purposes. The global market is projected to grow steadily from 2024 to 2030, achieving significant revenue milestones, driven largely by services and informatics segments. ...

The recent introduction of ChatGPT from artificial intelligence (AI) firm OpenAI has captured the imagination of the world and moved AI further into mainstream conversation. ChatGPT is “humanizing” AI in a way that has not been experienced before, generating impressive content from relatively simple requests (or prompts) written in natural language...